Benitec Biopharma Inc.
BNTCNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for BNTC. That does not mean none is planned.
Get an email about BNTC's next catalysts
Track Benitec Biopharma (BNTC) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
BB-401 | Phase 2 | Head and Neck Squamous Cell Carcinoma | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Benitec Biopharma Inc.'s drug pipeline?β
CatalystAlert tracks 1 drug candidate in Benitec Biopharma Inc.'s (BNTC) pipeline across Phase 2. Its lead program is BB-401 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Benitec Biopharma Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Benitec Biopharma Inc. (BNTC) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track BNTC biotech catalysts?β
Add BNTC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Benitec Biopharma Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
